Illumina wins fast-track appeal of FTC order to offload Grail
A U.S. appeals court on Tuesday said it will accelerate reviewing Illumina Inc's challenge to a federal agency order requiring the biotechnology company to divest cancer diagnostic test maker... | April 19, 2023